Journal of Virology, February 2001, p. 1205-1210, Vol. 75, No. 3
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.3.1205-1210.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

andPest Animal Control Cooperative Research Centre, CSIRO Sustainable Ecosystems,1 and Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University,2 Canberra, Australia
Received 25 July 2000/Accepted 13 November 2000
Genetic resistance to clinical mousepox (ectromelia virus) varies among inbred laboratory mice and is characterized by an effective natural killer (NK) response and the early onset of a strong CD8+ cytotoxic T-lymphocyte (CTL) response in resistant mice. We have investigated the influence of virus-expressed mouse interleukin-4 (IL-4) on the cell-mediated response during infection. It was observed that expression of IL-4 by a thymidine kinase-positive ectromelia virus suppressed cytolytic responses of NK and CTL and the expression of gamma interferon by the latter. Genetically resistant mice infected with the IL-4-expressing virus developed symptoms of acute mousepox accompanied by high mortality, similar to the disease seen when genetically sensitive mice are infected with the virulent Moscow strain. Strikingly, infection of recently immunized genetically resistant mice with the virus expressing IL-4 also resulted in significant mortality due to fulminant mousepox. These data therefore suggest that virus-encoded IL-4 not only suppresses primary antiviral cell-mediated immune responses but also can inhibit the expression of immune memory responses.
Present address: Centre for Biomolecular Vaccine Technology,
Discipline of Immunology and Microbiology, University of Newcastle, Newcastle, New South Wales, Australia.
Present address: CSIRO Plant Industry, Canberra ACT, Australia.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|